Because of a lapse in government funding, the information on this website may not be up to date, transactions submitted via the website may not be processed, and the agency may not be able to respond to inquiries until appropriations are enacted. The NIH Clinical Center (the research hospital of NIH) is open. For more details about its operating status, please visit cc.nih.gov. Updates regarding government operating status and resumption of normal operations can be found at opm.gov.

Assessing Cancer Patient Tobacco Use

  1. Behavioral Research Program
  2. Tobacco Control Research Branch (TCRB)
  3. Assessing Cancer Patient Tobacco Use

Studies have demonstrated that cancer patients who smoke cigarettes at the time of diagnosis experience worse outcomes compared with people who previously or never smoked. They face increased difficulty with surgical wound healing; more treatment morbidity; reduced radiation and chemotherapy efficacy; reduced time to recurrence, progression, and second primary cancers; and increased mortality. There are still many unaddressed questions related to tobacco use by cancer patients, but research in that area was previously impeded by inadequate assessment of tobacco use after cancer diagnosis and a lack of valid, harmonized measures that are tailored to the trajectory of cancer diagnosis, treatment, and survivorship.

To facilitate that research, NCI partnered with the American Association for Cancer Research (AACR) to form the NCI-AACR Cancer Patient Tobacco Use Assessment Task Force (PDF), which in turn developed the Cancer Patient Tobacco Use Questionnaire (C-TUQ). The measures have undergone clinical testing and are now available for use in all cancer research.

Reports from the NCI-AACR Cancer Patient Tobacco Use Assessment Task Force

Funding Opportunities

View all Tobacco Control Funding Opportunities.

Resources

Archive

Contact

Stephanie Land, PhD

Stephanie Land, PhD

Program Director, Statistician

stephanie.land@nih.gov